Tracking Home Exercise After Stroke With the MiGo Tracker Device
Tests a device that monitors home exercise in adults with recent stroke.
Plain-language title generated from the registry record
Registry title: MiGo Tracker Remote Monitoring of Home Exercise After Stroke
Key facts
- Where
- Downey, United StatesSee the site
Where in United States
- Rancho Research Institute, IncDowney, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Flint Rehabilitation Devices, LLC
- Trial code
- NCT06752707
- Record updated
- 16 July 2025
- Original description
This project will determine the safety and effectiveness of a MiGo Tracker RTM program in a randomized controlled trial with individuals with subacute stroke (N=50). Participants will be randomly assigned to either the MiGo Tracker RTM program (intervention group) or prescription of home exercises with no monitoring (usual care/control group). All participants will still receive usual post-stroke care, including outpatient rehabilitation. The main question this study aims to answer is: Does a MiGo Tracker RTM program lead to significantly greater motor recovery at three-months post stroke than the usual care group. If successful, MiGo Tracker will lead to increased home exercise adherence and improved health outcomes for thousands of individuals following stroke.Read full original descriptionShow less
MiGo Tracker: Seamless Remote Therapeutic Monitoring of Exercise Adherence After Stroke
This project will determine the safety and effectiveness of a MiGo Tracker RTM program in a randomized controlled trial with individuals with subacute stroke (N=50). Participants will be randomly assigned to either the MiGo Tracker RTM program (intervention group) or prescription of home exercises with no monitoring (usual care/control group). All participants will still receive usual post-stroke care, including outpatient rehabilitation. The main question this study aims to answer is: Does a MiGo Tracker RTM program lead to significantly greater motor recovery at three-months post stroke than the usual care group. If successful, MiGo Tracker will lead to increased home exercise adherence and improved health outcomes for thousands of individuals following stroke.
Inclusion: Experienced one or more strokes less than one month (30 days) prior; Upper Extremity Fugl-Meyer Score > 5 and <= 55 out of 66; Absence of moderate to severe pain (<= 4 on the 10 point visual-analog pain scale).
Exclusion: Other severe concurrent medical conditions that may prevent the participants from completing the 3-month study; Other neurological diagnosis (e.g. Parkinson's Disease); age <18 years old; Unable to follow 2-step commands.